ARCHIVES

DCE Board Approves Concept For studies Of Thorotrast Exposure

This article is from The Cancer Letter archive.

Vol. 16 No. 44 | November 16, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

NIH Investigating Cohn Records Leak

August 15, 1986

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

New Community Center Assnt. Determined To Improve Quality Of Care “With Or Without” NCI Assistance

September 27, 1974

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006